Filtros de búsqueda

Lista de obras de Tjalf Ziemssen

36 Months Pangaea: A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice

artículo científico publicado en 2015

6-sulpho LacNAc(+) dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous system

artículo científico publicado en 2016

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

artículo científico publicado en 2014

A Novel, Integrative Approach for Evaluating Progression in Multiple Sclerosis: Development of a Scoring Algorithm

scientific article published on 14 April 2020

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

artículo científico publicado en 2020

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

artículo científico publicado en 2019

A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies

scientific article published on 01 August 2007

A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe

artículo científico publicado en 2014

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

artículo científico publicado en 2017

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis

artículo científico publicado en 2014

ActiGait implantable drop foot stimulator in multiple sclerosis: a new indication

artículo científico publicado en 2016

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.

artículo científico publicado en 2016

Acute hyperlipidemia but not hyperhomocysteinemia impairs reflex regulation of the cardiovascular system

artículo científico publicado en 2015

Adrenal medullary dysfunction as a feature of obesity

artículo científico publicado en 2017

Adult polyglucosan body disease: a postmortem correlation study

artículo científico publicado en 2003

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

artículo científico publicado en 2017

An Innovative Technique to Assess Spontaneous Baroreflex Sensitivity with Short Data Segments: Multiple Trigonometric Regressive Spectral Analysis

artículo científico publicado en 2018

Anodal tDCS affects neuromodulatory effects of the norepinephrine system on superior frontal theta activity during response inhibition

artículo científico publicado en 2019

Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients - an observational study

artículo científico publicado en 2013

Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

scientific article published on 01 January 2019

Attenuated NOx responses and myocardial ischemia, a possible risk for structural vascular disease in African men: the SABPA study

artículo científico publicado en 2014

Attenuated brain-derived neurotrophic factor and hypertrophic remodelling: the SABPA study

artículo científico publicado en 2014

Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients

scientific article published on 18 August 2020

Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires

artículo científico publicado en 2005

Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up.

artículo científico publicado en 2017

Autonomic dysfunction in different subtypes of multiple system atrophy

artículo científico publicado en 2008

Autonomic dysfunction in patients with progressive supranuclear palsy

scientific article published on 01 October 2008

Autonomic function and cerebral autoregulation in patients undergoing carotid endarterectomy

artículo científico publicado en 2010

Autonomic responses to stress in Black versus Caucasian Africans: the SABPA study

artículo científico publicado en 2011

Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy

artículo científico publicado en 2014

Baroreceptor sensitivity, cardiovascular responses and ECG left ventricular hypertrophy in men: the SABPA study

artículo científico publicado en 2011

Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes

artículo científico publicado en 2010

Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes

artículo científico publicado en 2008

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings

Brain-immune communication psychoneuroimmunology of multiple sclerosis

artículo científico publicado en 2007

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.

artículo científico publicado en 2010

Cardiovascular autonomic dysfunction in Parkinson's disease

artículo científico publicado en 2009

Cardiovascular autonomic testing in extrapyramidal disorders

artículo científico

Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.

artículo científico publicado en 2011

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA.

artículo científico publicado en 2017

Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis

scientific article published on 30 August 2019

Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" Multiple Sclerosis and Related Disorders 2017

artículo científico publicado en 2018

Comparison of baroreflex sensitivity estimated from ECG R-R and inter-systolic intervals obtained by finger plethysmography and radial tonometry

artículo científico publicado en 2016

Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

artículo científico publicado en 2009

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

artículo científico publicado en 2010

Correction to: Differentiating societal costs of disability worsening in multiple sclerosis

artículo científico publicado en 2020

Cortisol awakening response is linked to disease course and progression in multiple sclerosis

artículo científico publicado en 2013

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease (CAPTURE PD): Protocol for a Multicenter Study

artículo científico publicado en 2017

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

article

Defensive active coping facilitates chronic hyperglycaemia and endothelial dysfunction in African men: the SABPA study

artículo científico publicado en 2012

Defensive coping facilitates higher blood pressure and early sub-clinical structural vascular disease via alterations in heart rate variability: the SABPA study.

artículo científico publicado en 2013

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry - Implications for the norepinephrine system during inhibitory control

artículo científico publicado en 2017

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

artículo científico publicado en 2016

Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System

artículo científico publicado en 2016

Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod

artículo científico publicado en 2017

Determination of baroreflex sensitivity during the modified Oxford maneuver by trigonometric regressive spectral analysis

artículo científico publicado en 2011

Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).

artículo científico publicado en 2016

Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.

artículo científico publicado en 2014

Different responses of the retinal and cutaneous microcirculation to transient dysmetabolic conditions

artículo científico publicado en 2015

Differentiating societal costs of disability worsening in multiple sclerosis

artículo científico publicado en 2019

Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

artículo científico publicado en 2019

Dual-Tasking in Multiple Sclerosis - Implications for a Cognitive Screening Instrument

artículo científico publicado en 2018

Dynamic formation of macular microcysts independent of vitreous traction changes

artículo científico publicado en 2015

Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study

scientific article published on 26 June 2019

Education research: cognitive performance is preserved in sleep-deprived neurology residents

artículo científico publicado en 2009

Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial

article

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

artículo científico publicado en 2018

Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid

artículo científico publicado en 2016

Effects of acute and chronic stress on the L-arginine nitric oxide pathway in black and white South Africans: the sympathetic activity and ambulatory blood pressure in Africans study

artículo científico publicado en 2013

Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

artículo científico publicado en 2008

Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial

artículo científico publicado en 2014

Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial

artículo científico publicado en 2015

Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study

artículo científico publicado en 2020

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

scientific article published on 25 November 2019

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies

artículo científico publicado en 2019

Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study

artículo científico publicado en 2017

Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors

artículo científico publicado en 2013

Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.

artículo científico publicado en 2018

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

artículo científico publicado en 2015

Ethnic-specific correlations of visfatin with circulating markers of endothelial inflammation and function

artículo científico publicado en 2009

Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review

artículo científico publicado en 2015

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial

artículo científico publicado en 2013

Exploring individual multiple sclerosis lesion volume change over time: Development of an algorithm for the analyses of longitudinal quantitative MRI measures

scientific article published on 03 December 2018

Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study

artículo científico publicado en 2012

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

artículo científico publicado en 2017

Fatigue and Sleep in Multiple Sclerosis Patients: A Comparison of Self-Report and Performance-Based Measures

artículo científico publicado en 2017

Fear of falling and falls in people with multiple sclerosis: A literature review

artículo científico publicado en 2020

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

artículo científico publicado en 2017

Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis

artículo científico

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease

artículo científico publicado en 2014

Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders

artículo científico publicado en 2011

Gender disparities in health resource utilization in patients with relapsing-remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

scientific article published on 24 October 2020

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor

artículo científico publicado en 2002

Glatiramer acetate: mechanisms of action in multiple sclerosis

artículo científico publicado en 2007

Glatiramer acetate: mechanisms of action in multiple sclerosis

artículo científico publicado en 2007

Graves' disease after treatment with alemtuzumab for multiple sclerosis

artículo científico publicado en 2015

Greater cardiovascular reactivity to a cold stimulus is due to higher cold pain perception in black Africans: the Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study

artículo científico publicado en 2012

Hands on Alemtuzumab-experience from clinical practice: whom and how to treat

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study

artículo científico publicado en 2020

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment

artículo científico publicado en 2017

Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination

artículo científico publicado en 2016

How minimal variations in neuronal cytoskeletal integrity modulate cognitive control

artículo científico publicado en 2018

How the depth of processing modulates emotional interference - evidence from EEG and pupil diameter data

scientific article published on 01 October 2019

How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians' Preferences

scientific article published on 14 February 2020

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

artículo científico publicado en 2020

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease

artículo científico publicado en 2012

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management

scientific article published on 20 February 2019

Immunoadsorption with regenerating systems in neurological disorders --A single center experience

artículo científico publicado en 2015

Immunomodulatory treatments and cognition in MS.

artículo científico publicado en 2016

Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation

artículo científico publicado en 2016

Implementation of the National Guidelines for the treatment of Diabetes mellitus type 2 in secondary diabetes centers

artículo científico publicado en 2017

Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach

artículo científico publicado en 2018

Improving patient-physician dialog: commentary on the results of the MS Choices survey.

artículo científico publicado en 2012

In vitro modulation of steroid 5alpha-reductase activity by phospholipases in epithelium and stroma of human benign prostatic hyperplasia

artículo científico publicado en 2001

Induction therapy for the management of early relapsing forms of multiple sclerosis. A critical opinion

artículo científico publicado en 2017

Influence of ECG sampling frequency on spectral analysis of RR intervals and baroreflex sensitivity using the EUROBAVAR data set.

artículo científico publicado en 2008

Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals

artículo científico publicado en 2015

Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study

artículo científico publicado en 2008

International consensus on quality standards for brain health-focused care in multiple sclerosis

article

LDL apheresis improves deranged cardiovagal modulation in hypercholesterolemic patients

artículo científico publicado en 2010

Laquinimod in the treatment of relapsing remitting multiple sclerosis

artículo científico publicado en 2016

Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".

artículo científico publicado en 2017

Letter to the editor regarding "Therapeutic drug monitoring of natalizumab"

scientific article published on 03 April 2019

Letter to the editor to the paper: "Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis".

artículo científico publicado en 2018

Limited Time from the Diabetes Patients' Perspective: Need for Conversation with the Eye Specialist

artículo científico publicado en 2016

Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells

artículo científico publicado en 2013

Local endothelial dysfunction does not affect global endothelial function

artículo científico publicado en 2015

Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis

artículo científico publicado el 1 de noviembre de 2011

Long-term safety and tolerability of glatiramer acetate 20 mg/ml in the treatment of relapsing forms of multiple sclerosis

artículo científico publicado en 2016

Loss of nocturnal blood pressure fall in various extrapyramidal syndromes

artículo científico publicado en 2009

Management of fingolimod in clinical practice

artículo científico publicado en 2013

Metabolic and Non-Metabolic Peripheral Neuropathy: Is there a Place for Therapeutic Apheresis?

artículo científico publicado en 2019

Metabolomic distinction of microvascular effects of lipoprotein apheresis--a pilot study

scientific article published on 01 January 2013

Modern communication technology skills of patients with multiple sclerosis

artículo científico publicado en 2013

Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis

artículo científico publicado en 2005

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis

artículo científico publicado en 2017

Molecular biomarkers in multiple sclerosis

artículo científico publicado en 2019

Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action

artículo científico publicado en 2016

Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion

scientific article published on 31 May 2018

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

artículo científico publicado en 2016

Multiple sclerosis and the autonomic nervous system

artículo científico publicado en 2006

Multiple sclerosis beyond EDSS: depression and fatigue

scientific article published on February 2009

Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients

artículo científico publicado en 2013

Multiple sclerosis in the real world: A systematic review of fingolimod as a case study.

artículo científico publicado en 2017

Multiple sclerosis registries in Europe - An updated mapping survey

artículo científico publicado en 2018

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach

artículo científico publicado en 2016

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients

scientific article published on 01 July 2019

Natalizumab during pregnancy and lactation

artículo científico publicado en 2017

Neuroborreliosis during natalizumab treatment in multiple sclerosis

artículo científico publicado en 2013

Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis

artículo científico publicado en 2009

Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis.

artículo científico publicado en 2004

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

artículo científico publicado en 2016

Nocturnal blood pressure, 3-methoxy-4-hydroxyphenylglycol and carotid intima-media thickness: The SABPA study

artículo científico publicado en 2013

Non-motor dysfunction in Parkinson's disease

artículo científico publicado en 2007

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device-A Proof of Concept Study in Multiple Sclerosis

artículo científico publicado en 2020

On the interrelation of 1/f neural noise and norepinephrine system activity during motor response inhibition

scientific article published on 27 February 2019

Optimizing therapy early in multiple sclerosis: An evidence-based view

artículo científico publicado en 2015

Optimizing treatment success in multiple sclerosis

artículo científico publicado en 2016

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).

artículo científico publicado en 2015

Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany

artículo científico publicado en 2018

Patients' preferences for involvement in the decision-making process for treating diabetic retinopathy

artículo científico publicado en 2017

Perceptions on the value of bodily functions in multiple sclerosis

artículo científico publicado en 2017

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

scientific article published on 03 April 2020

Perspectives of an innovative ophthalmological technology: optical coherence tomography (OCT)--what should be of interest to the neurologist?

artículo científico

Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects

artículo científico publicado en 2008

Phospholipase A2 degradation products modulate epithelial and stromal 5alpha-reductase activity of human benign prostatic hyperplasia in vitro

artículo científico publicado en 2002

Physician-patient communication skills: e-tools

artículo científico publicado en 2015

Pneumocystis pneumonia in a patient treated with alemtuzumab for relapsing multiple sclerosis

artículo científico publicado en 2019

Potential side effect of high-dose corticosteroid relapse treatment: acute generalized exanthematous pustulosis (AGEP).

artículo científico publicado en 2008

Predictors of response to opicinumab in acute optic neuritis

article

Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS

article

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting

scholarly article by Philipp Albrecht et al published 2018 in Therapeutic advances in neurological disorders

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

artículo científico publicado en 2020

Psychoneuroimmunology - Psyche and Autoimmunity ⬇️

artículo científico publicado el 1 de enero de 2012

Psychoneuroimmunology--cross-talk between the immune and nervous systems

artículo científico publicado en 2007

Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes

artículo científico publicado en 2007

Pupillary responses to intranasal trigeminal and olfactory stimulation

artículo científico publicado en 2009

QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.

artículo científico publicado en 2016

Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report

artículo científico publicado en 2010

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).

artículo científico publicado en 2016

Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

scientific article published on 01 October 2018

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

scholarly article

Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up

scholarly article

Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany

article

Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2019

Recent perspectives in neurology

artículo científico publicado en 2013

Recognition and treatment of autonomic disturbances in Parkinson's disease

artículo científico

Regular lipoprotein apheresis maintains residual cardiovascular and microvascular function in patients with advanced atherosclerotic disease

artículo científico publicado en 2013

Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis

artículo científico publicado en 2009

Relapses in multiple sclerosis reported by patients versus physicians - Insights from a large observational study

artículo científico publicado en 2020

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis

artículo científico publicado en 2018

Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis"

scientific article published on 30 May 2019

Response to: Kobayashi et al.: "Erythroblast appearance associated with natalizumab" Multiple Sclerosis and Related Disorders 2019

artículo científico publicado en 2019

Response to: S. Sega-Jazbec et al.: "Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis" Multiple Sclerosis and Related Disorders 2017.

artículo científico publicado en 2017

Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresis

artículo científico publicado en 2009

Review: Patient-reported outcomes in multiple sclerosis care

scientific article published on 27 May 2019

Review: Treatment of dysautonomia in extrapyramidal disorders ⬇️

artículo científico publicado el 1 de enero de 2010

Risk-benefit assessment of glatiramer acetate in multiple sclerosis

artículo científico publicado en 2001

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

artículo científico

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

artículo científico publicado en 2017

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

artículo científico publicado en 2017

Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma

artículo científico publicado en 2014

Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy

artículo científico publicado en 2005

Seizures associated with zoledronic acid for osteoporosis

artículo científico publicado en 2011

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

artículo científico publicado en 2013

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

artículo científico publicado en 2018

Spectral Analysis of Heart Rate Variability: Time Window Matters.

artículo científico publicado en 2019

Static posturography in aging and Parkinson's disease

artículo científico publicado en 2012

Stroke-induced immunodepression: experimental evidence and clinical relevance

artículo científico publicado en 2007

Study Protocol of AMASIA, a Non-Interventional Study to Gain First Insights on SPMS Patients Treated With Siponimod in Clinical Routine

artículo científico publicado en 2020

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod

artículo científico publicado en 2016

Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate

artículo científico publicado en 2015

Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease

artículo científico publicado en 2017

Sudomotor Testing of Diabetes Polyneuropathy

Symptom management in patients with multiple sclerosis ⬇️

artículo científico publicado el 1 de diciembre de 2011

Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidence

scientific article published on 18 January 2019

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

article

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

artículo científico publicado en 2020

The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice

artículo científico publicado en 2015

The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis

artículo científico publicado en 2004

The cold hand sign in multiple system atrophy: skin perfusion revisited

scientific article published on 12 February 2010

The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects

artículo científico publicado en 2007

The effects of venlafaxine on autonomic functions in healthy volunteers

artículo científico publicado en 2007

The importance of collecting structured clinical information on multiple sclerosis

artículo científico publicado en 2016

The norepinephrine system affects specific neurophysiological subprocesses in the modulation of inhibitory control by working memory demands

artículo científico publicado en 2016

The norepinephrine system and its relevance for multi-component behavior

artículo científico publicado en 2016

The norepinephrine system shows information-content specific properties during cognitive control - Evidence from EEG and pupillary responses

artículo científico publicado en 2017

The role of phasic norepinephrine modulations during task switching: evidence for specific effects in parietal areas

artículo científico publicado en 2017

The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).

artículo científico publicado en 2005

The sensory channel of presentation alters subjective ratings and autonomic responses toward disgusting stimuli-Blood pressure, heart rate and skin conductance in response to visual, auditory, haptic and olfactory presented disgusting stimuli

artículo científico publicado en 2013

Therapeutic decisions in multiple sclerosis: moving beyond efficacy

artículo científico publicado en 2013

Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey

scientific article published on 15 March 2016

Time matters - acute stress response and glucocorticoid sensitivity in early multiple sclerosis

artículo científico publicado en 2014

Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease

artículo científico publicado en 2014

To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the question

artículo científico publicado en 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

artículo científico publicado en 2017

Treatment of dysautonomia in extrapyramidal disorders

artículo científico publicado en 2011

Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies

artículo científico publicado en 2002

Treatment optimization in multiple sclerosis: how do we apply emerging evidence?

artículo científico publicado en 2017

Treatment strategies for nonmotor manifestations of Parkinson's disease.

scholarly article by Heinz Reichmann & Tjalf Ziemssen published 2009 in Expert Opinion on Pharmacotherapy

Trigonometric regressive spectral analysis reliably maps dynamic changes in baroreflex sensitivity and autonomic tone: the effect of gender and age.

artículo científico publicado en 2010

Trigonometric regressive spectral analysis: an innovative tool for evaluating the autonomic nervous system

artículo científico

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.

artículo científico publicado en 2017

Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study

artículo científico publicado en 2012

Valsalva manoeuvre in patients with different Parkinsonian disorders

artículo científico publicado en 2009

What can we learn from failed clinical trials in multiple sclerosis?

artículo científico publicado en 2008

[Adherence to neurologic treatment. Lessons from multiple sclerosis]

artículo científico publicado en 2008

[Chronically ill and unemployed? A review on vocational status in multiple sclerosis]

scientific article published on 14 February 2013

[Enhancing monitoring of disease progression-remote sensoring in multiple sclerosis]

scientific article published on 01 December 2019

[Multiple sclerosis management system 3D. Moving from documentation towards management of patients]

artículo científico publicado en 2012

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

artículo científico publicado en 2017

[Stress-cardiomyopathy--a psychological phenomenon?]

artículo científico publicado en 2013

[Treatment of autonomic dysfunction in patients with extrapyramidal disorders]

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda